Get a drug application
curl --request GET \
--url https://api.pav.bio/v1/fda/applications/{application_key} \
--header 'Authorization: Bearer <token>'import requests
url = "https://api.pav.bio/v1/fda/applications/{application_key}"
headers = {"Authorization": "Bearer <token>"}
response = requests.get(url, headers=headers)
print(response.text)const options = {method: 'GET', headers: {Authorization: 'Bearer <token>'}};
fetch('https://api.pav.bio/v1/fda/applications/{application_key}', options)
.then(res => res.json())
.then(res => console.log(res))
.catch(err => console.error(err));package main
import (
"fmt"
"net/http"
"io"
)
func main() {
url := "https://api.pav.bio/v1/fda/applications/{application_key}"
req, _ := http.NewRequest("GET", url, nil)
req.Header.Add("Authorization", "Bearer <token>")
res, _ := http.DefaultClient.Do(req)
defer res.Body.Close()
body, _ := io.ReadAll(res.Body)
fmt.Println(string(body))
}{
"application": {
"record_key": "purple_book_product:761508:001",
"record_type": "purple_book_product",
"source": "purple_book",
"title": "GENGLYCOS",
"source_version": "2026-08",
"fda_organization_name": "Regeneron Pharmaceuticals, Inc.",
"company": {
"company_id": 5093,
"short_name": "regeneron",
"name": "Regeneron Pharmaceuticals"
},
"application_key": "BLA:761508",
"product_key": "BLA:761508:001",
"designation_id": "1186826",
"patent_number": "10022461",
"description": "<string>",
"document_date": "2023-12-25",
"event_date": "2023-12-25",
"event_date_type": "patent_expiry",
"status": "RX",
"source_url": "<string>",
"details": {
"ingredient": "SEMAGLUTIDE",
"strength": "300MG/5ML (60MG/ML)",
"dosage_route": "TABLET;ORAL",
"dosage_form": "Injection",
"route": "Intravenous",
"therapeutic_equivalence_code": "AB1",
"reference_listed_drug": true,
"reference_standard": true,
"patent_use_code": "U-4597",
"pediatric_extension": true,
"drug_substance_claim": true,
"drug_product_claim": true,
"license_type": "351(a)",
"licensure": "Licensed",
"license_number": "1760",
"orphan_exclusivity_expiry": "2023-12-25",
"reference_product_exclusivity_expiry": "2023-12-25",
"approval_date_raw": "Approved Prior to Jan 1, 1982",
"generic_name": "inosine pranobex",
"designation_withdrawn_date": "2023-12-25",
"approvals": [
{
"marketing_approval_date": "2023-12-25",
"exclusivity_end_date": "2023-12-25",
"trade_name": "Darzalex",
"generic_name": "daratumumab",
"approved_labeled_indication": "<string>",
"protected_indication": "<string>"
}
],
"brand": "Baxter",
"reason": "Mislabeling",
"reason_description": "<string>",
"product_types": [
"Drugs"
],
"issuing_office": "Center for Drug Evaluation and Research (CDER)",
"fda_reference_id": "738238",
"closeout_date": "2023-12-25",
"application_type": "NDA",
"products": "NUBEQA",
"submission_count": 123,
"latest_submission": {
"submission_type": "SUPPL",
"submission_number": "16",
"status": "AP",
"status_date": "2023-12-25",
"submission_class": "Labeling",
"review_priority": "PRIORITY",
"notes": "<string>"
},
"letter_type": "COMPLETE RESPONSE",
"application_numbers": [
"NDA 218705"
],
"category": "cancer",
"current_status": "Traditional Approval Granted (12/16/2022)",
"confirmatory_requirements": [
{
"requirement": "<string>",
"projected_completion": "2023-12-25"
}
],
"center": "Center for Drug Evaluation and Research",
"meeting_start": "2023-11-07T05:31:56Z",
"meeting_end": "2023-11-07T05:31:56Z",
"documents": [
{
"title": "<string>",
"url": "<string>",
"document_type": "<string>",
"document_date": "2023-12-25"
}
]
}
},
"records": [
{
"record_key": "purple_book_product:761508:001",
"record_type": "purple_book_product",
"source": "purple_book",
"title": "GENGLYCOS",
"source_version": "2026-08",
"fda_organization_name": "Regeneron Pharmaceuticals, Inc.",
"company": {
"company_id": 5093,
"short_name": "regeneron",
"name": "Regeneron Pharmaceuticals"
},
"application_key": "BLA:761508",
"product_key": "BLA:761508:001",
"designation_id": "1186826",
"patent_number": "10022461",
"description": "<string>",
"document_date": "2023-12-25",
"event_date": "2023-12-25",
"event_date_type": "patent_expiry",
"status": "RX",
"source_url": "<string>",
"details": {
"ingredient": "SEMAGLUTIDE",
"strength": "300MG/5ML (60MG/ML)",
"dosage_route": "TABLET;ORAL",
"dosage_form": "Injection",
"route": "Intravenous",
"therapeutic_equivalence_code": "AB1",
"reference_listed_drug": true,
"reference_standard": true,
"patent_use_code": "U-4597",
"pediatric_extension": true,
"drug_substance_claim": true,
"drug_product_claim": true,
"license_type": "351(a)",
"licensure": "Licensed",
"license_number": "1760",
"orphan_exclusivity_expiry": "2023-12-25",
"reference_product_exclusivity_expiry": "2023-12-25",
"approval_date_raw": "Approved Prior to Jan 1, 1982",
"generic_name": "inosine pranobex",
"designation_withdrawn_date": "2023-12-25",
"approvals": [
{
"marketing_approval_date": "2023-12-25",
"exclusivity_end_date": "2023-12-25",
"trade_name": "Darzalex",
"generic_name": "daratumumab",
"approved_labeled_indication": "<string>",
"protected_indication": "<string>"
}
],
"brand": "Baxter",
"reason": "Mislabeling",
"reason_description": "<string>",
"product_types": [
"Drugs"
],
"issuing_office": "Center for Drug Evaluation and Research (CDER)",
"fda_reference_id": "738238",
"closeout_date": "2023-12-25",
"application_type": "NDA",
"products": "NUBEQA",
"submission_count": 123,
"latest_submission": {
"submission_type": "SUPPL",
"submission_number": "16",
"status": "AP",
"status_date": "2023-12-25",
"submission_class": "Labeling",
"review_priority": "PRIORITY",
"notes": "<string>"
},
"letter_type": "COMPLETE RESPONSE",
"application_numbers": [
"NDA 218705"
],
"category": "cancer",
"current_status": "Traditional Approval Granted (12/16/2022)",
"confirmatory_requirements": [
{
"requirement": "<string>",
"projected_completion": "2023-12-25"
}
],
"center": "Center for Drug Evaluation and Research",
"meeting_start": "2023-11-07T05:31:56Z",
"meeting_end": "2023-11-07T05:31:56Z",
"documents": [
{
"title": "<string>",
"url": "<string>",
"document_type": "<string>",
"document_date": "2023-12-25"
}
]
}
}
],
"records_total": 546,
"submissions": [
{
"submission_type": "SUPPL",
"submission_number": "16",
"status": "AP",
"status_date": "2023-12-25",
"submission_class": "Labeling",
"review_priority": "PRIORITY",
"notes": "<string>"
}
],
"submissions_total": 45
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}FDA
Get a drug application
One application with every FDA record on it and its submissions, newest first. records_total and submissions_total count everything on it.
GET
/
v1
/
fda
/
applications
/
{application_key}
Get a drug application
curl --request GET \
--url https://api.pav.bio/v1/fda/applications/{application_key} \
--header 'Authorization: Bearer <token>'import requests
url = "https://api.pav.bio/v1/fda/applications/{application_key}"
headers = {"Authorization": "Bearer <token>"}
response = requests.get(url, headers=headers)
print(response.text)const options = {method: 'GET', headers: {Authorization: 'Bearer <token>'}};
fetch('https://api.pav.bio/v1/fda/applications/{application_key}', options)
.then(res => res.json())
.then(res => console.log(res))
.catch(err => console.error(err));package main
import (
"fmt"
"net/http"
"io"
)
func main() {
url := "https://api.pav.bio/v1/fda/applications/{application_key}"
req, _ := http.NewRequest("GET", url, nil)
req.Header.Add("Authorization", "Bearer <token>")
res, _ := http.DefaultClient.Do(req)
defer res.Body.Close()
body, _ := io.ReadAll(res.Body)
fmt.Println(string(body))
}{
"application": {
"record_key": "purple_book_product:761508:001",
"record_type": "purple_book_product",
"source": "purple_book",
"title": "GENGLYCOS",
"source_version": "2026-08",
"fda_organization_name": "Regeneron Pharmaceuticals, Inc.",
"company": {
"company_id": 5093,
"short_name": "regeneron",
"name": "Regeneron Pharmaceuticals"
},
"application_key": "BLA:761508",
"product_key": "BLA:761508:001",
"designation_id": "1186826",
"patent_number": "10022461",
"description": "<string>",
"document_date": "2023-12-25",
"event_date": "2023-12-25",
"event_date_type": "patent_expiry",
"status": "RX",
"source_url": "<string>",
"details": {
"ingredient": "SEMAGLUTIDE",
"strength": "300MG/5ML (60MG/ML)",
"dosage_route": "TABLET;ORAL",
"dosage_form": "Injection",
"route": "Intravenous",
"therapeutic_equivalence_code": "AB1",
"reference_listed_drug": true,
"reference_standard": true,
"patent_use_code": "U-4597",
"pediatric_extension": true,
"drug_substance_claim": true,
"drug_product_claim": true,
"license_type": "351(a)",
"licensure": "Licensed",
"license_number": "1760",
"orphan_exclusivity_expiry": "2023-12-25",
"reference_product_exclusivity_expiry": "2023-12-25",
"approval_date_raw": "Approved Prior to Jan 1, 1982",
"generic_name": "inosine pranobex",
"designation_withdrawn_date": "2023-12-25",
"approvals": [
{
"marketing_approval_date": "2023-12-25",
"exclusivity_end_date": "2023-12-25",
"trade_name": "Darzalex",
"generic_name": "daratumumab",
"approved_labeled_indication": "<string>",
"protected_indication": "<string>"
}
],
"brand": "Baxter",
"reason": "Mislabeling",
"reason_description": "<string>",
"product_types": [
"Drugs"
],
"issuing_office": "Center for Drug Evaluation and Research (CDER)",
"fda_reference_id": "738238",
"closeout_date": "2023-12-25",
"application_type": "NDA",
"products": "NUBEQA",
"submission_count": 123,
"latest_submission": {
"submission_type": "SUPPL",
"submission_number": "16",
"status": "AP",
"status_date": "2023-12-25",
"submission_class": "Labeling",
"review_priority": "PRIORITY",
"notes": "<string>"
},
"letter_type": "COMPLETE RESPONSE",
"application_numbers": [
"NDA 218705"
],
"category": "cancer",
"current_status": "Traditional Approval Granted (12/16/2022)",
"confirmatory_requirements": [
{
"requirement": "<string>",
"projected_completion": "2023-12-25"
}
],
"center": "Center for Drug Evaluation and Research",
"meeting_start": "2023-11-07T05:31:56Z",
"meeting_end": "2023-11-07T05:31:56Z",
"documents": [
{
"title": "<string>",
"url": "<string>",
"document_type": "<string>",
"document_date": "2023-12-25"
}
]
}
},
"records": [
{
"record_key": "purple_book_product:761508:001",
"record_type": "purple_book_product",
"source": "purple_book",
"title": "GENGLYCOS",
"source_version": "2026-08",
"fda_organization_name": "Regeneron Pharmaceuticals, Inc.",
"company": {
"company_id": 5093,
"short_name": "regeneron",
"name": "Regeneron Pharmaceuticals"
},
"application_key": "BLA:761508",
"product_key": "BLA:761508:001",
"designation_id": "1186826",
"patent_number": "10022461",
"description": "<string>",
"document_date": "2023-12-25",
"event_date": "2023-12-25",
"event_date_type": "patent_expiry",
"status": "RX",
"source_url": "<string>",
"details": {
"ingredient": "SEMAGLUTIDE",
"strength": "300MG/5ML (60MG/ML)",
"dosage_route": "TABLET;ORAL",
"dosage_form": "Injection",
"route": "Intravenous",
"therapeutic_equivalence_code": "AB1",
"reference_listed_drug": true,
"reference_standard": true,
"patent_use_code": "U-4597",
"pediatric_extension": true,
"drug_substance_claim": true,
"drug_product_claim": true,
"license_type": "351(a)",
"licensure": "Licensed",
"license_number": "1760",
"orphan_exclusivity_expiry": "2023-12-25",
"reference_product_exclusivity_expiry": "2023-12-25",
"approval_date_raw": "Approved Prior to Jan 1, 1982",
"generic_name": "inosine pranobex",
"designation_withdrawn_date": "2023-12-25",
"approvals": [
{
"marketing_approval_date": "2023-12-25",
"exclusivity_end_date": "2023-12-25",
"trade_name": "Darzalex",
"generic_name": "daratumumab",
"approved_labeled_indication": "<string>",
"protected_indication": "<string>"
}
],
"brand": "Baxter",
"reason": "Mislabeling",
"reason_description": "<string>",
"product_types": [
"Drugs"
],
"issuing_office": "Center for Drug Evaluation and Research (CDER)",
"fda_reference_id": "738238",
"closeout_date": "2023-12-25",
"application_type": "NDA",
"products": "NUBEQA",
"submission_count": 123,
"latest_submission": {
"submission_type": "SUPPL",
"submission_number": "16",
"status": "AP",
"status_date": "2023-12-25",
"submission_class": "Labeling",
"review_priority": "PRIORITY",
"notes": "<string>"
},
"letter_type": "COMPLETE RESPONSE",
"application_numbers": [
"NDA 218705"
],
"category": "cancer",
"current_status": "Traditional Approval Granted (12/16/2022)",
"confirmatory_requirements": [
{
"requirement": "<string>",
"projected_completion": "2023-12-25"
}
],
"center": "Center for Drug Evaluation and Research",
"meeting_start": "2023-11-07T05:31:56Z",
"meeting_end": "2023-11-07T05:31:56Z",
"documents": [
{
"title": "<string>",
"url": "<string>",
"document_type": "<string>",
"document_date": "2023-12-25"
}
]
}
}
],
"records_total": 546,
"submissions": [
{
"submission_type": "SUPPL",
"submission_number": "16",
"status": "AP",
"status_date": "2023-12-25",
"submission_class": "Labeling",
"review_priority": "PRIORITY",
"notes": "<string>"
}
],
"submissions_total": 45
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}{
"error": {
"code": "not_found",
"message": "program 999999 not found",
"request_id": "3f2b9c1d8a7e4f6b9c0d1e2f3a4b5c6d"
}
}Authorizations
Use a personal or organization Pav API key from Pav developer settings. Send it as Authorization: Bearer <api_key>.
Path Parameters
N: (NDA), A: (ANDA) or BLA: plus the application number.
Maximum string length:
32Pattern:
^(N|A|BLA):[0-9]{1,8}$Example:
"N:212099"
Response
Successful Response
The drug application.
Show child attributes
Show child attributes
Every other FDA record on this application.
Show child attributes
Show child attributes
Records on the application; equals len(records) unless capped.
Example:
546
The application's submissions and FDA actions, newest first.
Show child attributes
Show child attributes
How many submissions the application has.
Example:
45
⌘I